Skip to main content

Peer Review reports

From: Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial

Original Submission
19 Sep 2021 Submitted Original manuscript
29 Sep 2021 Author responded Author comments - Lutz van Heek
Resubmission - Version 2
29 Sep 2021 Submitted Manuscript version 2
13 Nov 2021 Author responded Author comments - Lutz van Heek
Resubmission - Version 3
13 Nov 2021 Submitted Manuscript version 3
24 Jan 2022 Reviewed Reviewer Report
27 Jan 2022 Reviewed Reviewer Report - Simonetta Viviani
19 Feb 2022 Reviewed Reviewer Report
21 Feb 2022 Reviewed Reviewer Report
13 Apr 2022 Author responded Author comments - Lutz van Heek
Resubmission - Version 4
13 Apr 2022 Submitted Manuscript version 4
2 May 2022 Reviewed Reviewer Report
3 May 2022 Reviewed Reviewer Report
19 May 2022 Author responded Author comments - Lutz van Heek
Resubmission - Version 5
19 May 2022 Submitted Manuscript version 5
1 Jun 2022 Author responded Author comments - Lutz van Heek
Resubmission - Version 6
1 Jun 2022 Submitted Manuscript version 6
Publishing
10 Jun 2022 Editorially accepted
18 Jun 2022 Article published 10.1186/s12885-022-09758-z

You can find further information about peer review here.

Back to article page